post-streptococcal glomerulonephritis
Jump to navigation
Jump to search
Etiology
- may follow group-A beta-hemolytic Streptococcal infection
- type 12 pharyngeal infection
- type 49 skin infection
- immune complex disease with localization of streptococcal antigen-antibody complexes & complement in renal glomeruli
Pathology
- many neutrophils (renal biopsy)
- diffuse proliferative glomerulonephritis
- glomeruli are markedly enlarged & hypercellular
- electron microscopy:
- subepithelial immune deposits or humps
- mesangial deposits
- crescents
- immunofluorescence demonstrates granular "lumpy-bumpy" pattern with IgG & C3
Clinical manifestations
- latent period
- type 12 pharyngeal infection: 6-21 days
- type 49 skin infection: 14-28 days
- suddent onset edema, hematuria, renal insufficiency
- see glomerulonephritis
Laboratory
- urinalysis
- active urine sediment
- proteinuria generally < 3 g/24 hours
- fractional excretion of sodium (FENA) <1%
- hematuria
- transiently low serum complement, CH50 & serum C3 (up to 8 weeks)
- antibodies against streptococcal antigens
- antistreptolysin-O (ASO) in positive with pharyngeal infections
- anti-DNAse B is positive with skin infections
- antihyaluronidase antibodies
- antistreptokinase antbodies
- a change in titer indicates recent infection
- renal biopsy
Management
- no specific therapy
- supportive: control of blood pressure & edema
- penicillin for the patient & contacts may prevent new cases
- prognosis is excellent unless crescents or persistent proteinuria is present
- recovery of renal function in several weeks
- proteinuria & hematuria resolve more slowly
More general terms
References
- ↑ Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 270
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 605
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11, 14, American College of Physicians, Philadelphia 1998, 2006